The global skin cancer diagnosis and therapeutics market are anticipated to grow at a considerable CAGR of around 7.5% during the forecast period (2021-2027). One of the major drivers of the market is the increasing demand for skin cancer therapies such as radiation therapy, chemotherapy, immunotherapy, and other drug therapy. There has been an increased adoption rate of these therapeutics among the patients, which is likely to increase the market growth. According to WHO, the rate of both non-melanoma and melanoma skin cancers has been increasing day by day. Around 3 million non-melanoma skin cancers, and 132,000 melanoma skin cancers occur across the globe. In addition to that, several government initiatives have proven to be favorable for the skin cancer diagnosis and therapeutics market. Besides, there is a lack of awareness among the patients in emerging countries about the availability of this form of treatment is a restraint of the market.
Browse the full report description of "Global Skin Cancer Diagnosis and Therapeutics Market Research By Type (Melanoma and Non-Melanoma), By Therapy (Surgery treatment, Radiotherapy, Chemotherapy, Targeted therapy, Immunotherapy, and Others), By Diagnosis (Dermatoscopy, Biopsy, Blood test, X-rays, and Others), Forecast, 2021-2027" at https://www.omrglobal.com/industry-reports/skin-cancer-diagnosis-and-therapeutics-market
In addition, to create opportunities the key players operating in the market have been inventing new drugs with FDA approval of several new immunotherapies. For instance, In June 2020, Merck & Co., Inc. received approval for pembrolizumab for cutaneous squamous cell carcinoma from the US Food and Drug Administration (FDA). The drug is used for the treatment of a patient having metastatic cutaneous squamous cell carcinoma (CSCC) that is not treatable by surgery or radiation.
Market Coverage
o By Type
o By Therapy
o ByDiagnosis
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Skin Cancer Diagnosis and Therapeutics Market
By Type
By Therapy
By Diagnosis
Global Skin Cancer Diagnosis and Therapeutics Market by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/skin-cancer-diagnosis-and-therapeutics-market